Table of Contents
ISRN Pulmonology
Volume 2013 (2013), Article ID 486507, 5 pages
http://dx.doi.org/10.1155/2013/486507
Clinical Study

Factors Influencing Sputum Conversion among Smear-Positive Pulmonary Tuberculosis Patients in Morocco

Respiratory Department, Moulay Youssef University Hospital, UM5S, 10000 Rabat, Morocco

Received 12 May 2013; Accepted 13 June 2013

Academic Editors: S. L. Chan, Y. Dobashi, and T. J. Kelley

Copyright © 2013 Khalid Bouti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Feng-Zeng, M. H. Levy, and W. Sumin, “Sputum microscopy results at two and three months predict outcome of tuberculosis treatment,” International Journal of Tuberculosis and Lung Disease, vol. 1, no. 6, pp. 570–572, 1997. View at Google Scholar · View at Scopus
  2. Centers for Disease Control and Prevention, “Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005,” Morbidity and Mortality Weekly Report, vol. 54, no. 17, pp. 1–141, 2005. View at Google Scholar · View at Scopus
  3. S. P. Agarwal and L. S. Chauhan, Tuberculosis Control in India, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi, India, 2005.
  4. A. F. Sirgel, J. Odhiambo, W. Githui et al., “A multicentre study of the early bactericidal activity of anti-tuberculosis drugs,” Journal of Antimicrobial Chemotherapy, vol. 45, no. 6, pp. 859–870, 2000. View at Google Scholar · View at Scopus
  5. T. Frieden, Ed., Toman’s Tuberculosis Case Detection, Treatment, and Monitoring—Questions and Answers, World Health Organisation, Geneva, Switzerland, 2nd edition, 2004.
  6. R. Long, K. Bochar, S. Chomyc et al., “Relative versus absolute noncontagiousness of respiratory Tuberculosis on treatment,” Infection Control and Hospital Epidemiology, vol. 24, no. 11, pp. 823–838, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Stop TB Department and World Health Organization, WHO Policy on TB infection control in healthcare-care facilities, congregate settings and households, World Health Organization, Geneva, Switzerland, 2009.
  8. P. Raunak, N. Gita, K. Swapna, K. Vijay, and M. Preeti, “Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it,” The Journal of the Association of Physicians of India, vol. 60, pp. 22–26, 2012. View at Google Scholar
  9. B. A. Fazal, E. E. Telzak, S. Blum et al., “Impact of a coordinated tuberculosis team in an inner-city hospital in New York City,” Infection Control and Hospital Epidemiolog, vol. 16, no. 6, pp. 340–343, 1995. View at Google Scholar · View at Scopus
  10. World Health Organization, “Global tuberculosis control: epidemiology, planning, financing,” WHO Report 2009, World Health Organization, Geneva, Switzerland, 2009. View at Google Scholar
  11. H. L. Rieder, “Sputum smear conversion during directly observed treatment for tuberculosis,” Tubercle and Lung Disease, vol. 77, no. 2, pp. 124–129, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Feng-Zeng, M. H. Levy, and W. Sumin, “Sputum microscopy results at two and three months predict outcome of tuberculosis treatment,” International Journal of Tuberculosis and Lung Disease, vol. 1, no. 6, pp. 570–572, 1997. View at Google Scholar · View at Scopus
  13. C. Lienhardt, K. Manneh, V. Bouchier, G. Lahai, P. J. M. Milligan, and K. P. W. J. McAdam, “Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in the Gambia,” International Journal of Tuberculosis and Lung Disease, vol. 2, no. 9, pp. 712–718, 1998. View at Google Scholar · View at Scopus
  14. C. Kuaban, R. Bame, L. Mouangue, S. Djella, and C. Yomgni, “Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon,” East African Medical Journal, vol. 86, no. 5, pp. 219–225, 2009. View at Google Scholar · View at Scopus
  15. A. Domínguez-Castellano, M. A. Muniain, J. Rodriguez-Baño et al., “Factors associated with time to sputum smear conversion in active pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 5, pp. 432–438, 2003. View at Google Scholar · View at Scopus
  16. M. Güler, E. Ünsal, B. Dursun et al., “Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis,” International Journal of Clinical Practice, vol. 61, no. 2, pp. 231–235, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Senkoro, S. G. Mfinanga, and O. Mørkve, “Smear microscopy and culture conversion rates among smear positive pulmonary tuberculosis patients by HIV status in Dar es Salaam, Tanzania,” BMC Infectious Diseases, vol. 10, article 210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Dautzenberg, “Tuberculose : prévention, isolement, hygiène,” Médecine et Maladies Infectieuses, vol. 25, no. 3, pp. 392–401, 1995. View at Publisher · View at Google Scholar
  19. Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Exelence NIfHaC, The National Collaborating Centre for Chronic Conditions 2006.
  20. R. Singla, M. M. Osman, N. Khan, N. Al-Sharif, M. O. Al-Sayegh, and M. A. Shaikh, “Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 1, pp. 58–64, 2003. View at Google Scholar · View at Scopus
  21. E. E. Telzak, B. A. Fazal, C. L. Pollard, G. S. Turett, J. E. Justman, and S. Blum, “Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis,” Clinical Infectious Diseases, vol. 25, no. 3, pp. 666–672, 1997. View at Google Scholar · View at Scopus
  22. V. V. Banu Rekha, R. Balasubramanian, S. Swaminathan et al., “Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors,” Indian Journal of Medical Research, vol. 126, no. 5, pp. 452–458, 2007. View at Google Scholar · View at Scopus
  23. J. Hiyama, M. Marukawa, Y. Shiota et al., “Factors influencing response to treatment of pulmonary tuberculosis,” Acta Medica Okayama, vol. 54, no. 4, pp. 139–145, 2000. View at Google Scholar · View at Scopus
  24. J. Y. Wang, L. N. Lee, C. J. Yu, Y. J. Chien, P. C. Yang, and Tami Group, “Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis,” Respirology, vol. 14, no. 7, pp. 1012–1019, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Horne, C. O. Johnson, E. Oren, C. Spitters, and M. Narita, “How soon should patients with smear-positive tuberculosis be released from inpatient isolation?” Infection Control and Hospital Epidemiology, vol. 31, no. 1, pp. 78–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Cauthen, S. W. Dooley, I. M. Onorato et al., “Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS,” American Journal of Epidemiology, vol. 144, no. 1, pp. 69–77, 1996. View at Google Scholar · View at Scopus
  27. A. Domínguez-Castellano, M. A. Muniain, J. Rodriguez-Baño et al., “Factors associated with time to sputum smear conversion in active pulmonary tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 5, pp. 432–438, 2003. View at Google Scholar · View at Scopus
  28. R. Singla, N. Khan, N. Al-Sharif, M. O. Al-Sayegh, M. A. Shaikh, and M. M. Osman, “Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients,” International Journal of Tuberculosis and Lung Disease, vol. 10, no. 1, pp. 74–79, 2006. View at Google Scholar · View at Scopus
  29. Z. Liu, K. L. Shilkret, and H. M. Ellis, “Predictors of sputum culture conversion among patients with tuberculosis in the era of tuberculosis resurgence,” Archives of Internal Medicine, vol. 159, no. 10, pp. 1110–1116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Slama, C. Y. Chiang, D. A. Enarson et al., “Tobacco and tuberculosis: a qualitative systematic review and meta-analysis,” International Journal of Tuberculosis and Lung Disease, vol. 11, no. 10, pp. 1049–1061, 2007. View at Google Scholar · View at Scopus
  31. C. C. Leung, W. W. Yew, C. K. Chan et al., “Smoking and tuberculosis in Hong Kong,” International Journal of Tuberculosis and Lung Disease, vol. 7, no. 10, pp. 980–986, 2003. View at Google Scholar · View at Scopus
  32. A. T. Abal, B. Jayakrishnan, S. Parwer, A. El Shamy, E. Abahussain, and P. N. Sharma, “Effect of cigarette smoking on sputum smear conversion in adults with active pulmonary tuberculosis,” Respiratory Medicine, vol. 99, no. 4, pp. 415–420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. Durban Immunotherapy Trial Group, “Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial,” The Lancet, vol. 354, no. 9173, pp. 116–119, 1999. View at Publisher · View at Google Scholar · View at Scopus